Adherence to evidence-based secondary prevention pharmacotherapy in patients after an acute coronary syndrome: A systematic review.

Heart & Lung : the Journal of Critical Care
Han-Yang ChenRobert J Goldberg

Abstract

To synthesize current evidence on medication adherence rates and associated risk factors in patients after an acute coronary syndrome (ACS). A systematic review was conducted. Five electronic databases and article bibliographies were searched for publications from 1990 to 2013 which assessed adherence to secondary prevention pharmacotherapy in adults after hospital discharge for an ACS. Identified studies were screened using pre-defined criteria for eligibility. A standardized form was used for data abstraction. Methodological quality was assessed using modified criteria for quantitative studies. Sixteen studies met our inclusion criteria. Post-discharge medication adherence rates at 1-year ranged between 54% and 86%. There were no consistent predictors of non-adherence across all cardiac medication classes examined. Adherence to secondary prevention pharmacotherapy was suboptimal in patients after hospital discharge for an ACS. Risk factors associated with non-adherence were examined in a limited number of studies, and the associations varied between these investigations.

References

Mar 10, 2001·JAMA : the Journal of the American Medical Association·U StenestrandUNKNOWN Swedish Register of Cardiac Intensive Care (RIKS-HIA)
Mar 28, 2003·American Heart Journal·Ewurabena SimpsonLouise Pilote
Dec 12, 2003·European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology·Sabina De Geest, Eduardo Sabaté
May 24, 2005·Medical Care·Michael C SokolRobert S Epstein
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke
Nov 4, 2005·The New England Journal of Medicine·Ronald J Campbell
Dec 15, 2005·International Journal of Clinical Practice·A A PetrillaE H Hazard
Jan 11, 2007·JAMA : the Journal of the American Medical Association·Jeppe N RasmussenDavid A Alter
Jul 5, 2007·JAMA : the Journal of the American Medical Association·Dana P GoldmanYuhui Zheng
Feb 2, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Joyce A CramerPeter K Wong
Jul 11, 2008·Clinical Journal of the American Society of Nephrology : CJASN·Wolfgang C WinkelmayerSoko Setoguchi
May 6, 2009·Health Affairs·Niteesh K ChoudhryWilliam H Shrank
Jun 17, 2009·Circulation·P Michael HoJohn S Rumsfeld
Oct 6, 2010·The American Journal of Cardiology·Ian M KronishKarina W Davidson
Nov 12, 2010·The New England Journal of Medicine·Niteesh K Choudhry, William H Shrank
Feb 3, 2011·JAMA : the Journal of the American Medical Association·R Neal Axon, Mark V Williams
Apr 1, 2011·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Vittorio MaioJoshua J Gagne
May 17, 2011·American Heart Journal·Nancy M Allen LaPointeKaren P Alexander
Jul 4, 2012·The American Journal of Medicine·Sayed H NaderiDavid S Wald
Sep 20, 2012·Circulation. Cardiovascular Quality and Outcomes·Molly E WaringUNKNOWN TRACE-CORE Investigators
Dec 19, 2012·Circulation·Patrick T O'GaraUNKNOWN American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Dec 20, 2012·Current Cardiology Reports·Nihar R Desai, Niteesh K Choudhry
Mar 20, 2013·The American Journal of Medicine·Asaf BittonWilliam H Shrank
May 23, 2013·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Beth L NordstromMark B Effron
Jun 5, 2013·Drugs & Aging·Camilla B PimentelBecky A Briesacher
Jul 11, 2013·Circulation. Cardiovascular Quality and Outcomes·Alexandra M HajdukJane S Saczynski
Dec 20, 2013·Circulation·Alan S GoUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee

❮ Previous
Next ❯

Citations

May 31, 2018·European Heart Journal. Cardiovascular Pharmacotherapy·Stefano AlbaniGianfranco Sinagra
Jan 27, 2017·Circulation·Emelia J BenjaminUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Feb 2, 2018·Circulation·Emelia J BenjaminUNKNOWN American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee
Jun 1, 2018·Journal of Public Health·K H LeslieJ P Pell
May 12, 2019·Systematic Reviews·Alina Gast, Tim Mathes
Jul 23, 2020·Scientific Reports·Łukasz PietrzykowskiAldona Kubica
Jul 14, 2019·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Christel BruggmannPierre Voirol
Apr 18, 2021·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Alessandro MalobertiCristina Giannattasio
Jun 2, 2021·Patient Education and Counseling·Łukasz PietrzykowskiAldona Kubica

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Clinical Pharmacy
Yaman KassabHadeer AbdulRazzaq
Journal of the American Pharmacists Association : JAPhA
Janet H DaileySarah A Spinler
© 2021 Meta ULC. All rights reserved